**1. Business Performance:** SHK, a leading Indian Fragrance & Flavour player, reported consistent revenue growth with FY25 Total Income at ₹2,147 Cr (5-yr CAGR ~10%). Cash profit was ₹224 Cr.

FY25 EBITDA hit ₹317 Cr (15.0% margin), showcasing strong operational resilience.

Gross margins are steady, highlighting a robust business model. **2. Growth Drivers or Strategy:** Strategy: Global expansion, product portfolio boost & R&D leverage.

SHK is expanding its footprint in Europe, North America, Middle East & Asia, while dominating India.

Growth is fueled by organic efforts, new Creation & Development Centres (CDCs), and operational efficiencies. **3. Recent Developments:** Recent moves: In 2024, SHK acquired Holland Aromatics B.V. balance stake, launched an Indonesia facility, & entered the US via Keva USA Inc. By 2025, new CDCs were set up in New Jersey, Hamburg, & Manchester for innovation & market reach. **4. Key Financial Metrics / 5. Management Commentary / Outlook:** FY25 metrics: Total Income ₹2,147 Cr, EBITDA ₹317 Cr, PAT ₹125 Cr.

Outlook: Sales projected to grow to ₹3,377 Cr by FY29P (13.5% CAGR), with EBITDA margins climbing to 13.9% & ROCE to 14.6%. Management sees strong growth from emerging markets, strategic developed market entry, & ongoing investments in high-potential geographies.

Sales expected ~15% growth.